GKB Ophthalmics Ltd.
Snapshot View

189.00 -2.05 ▼-1.1%

27 January 2023, 04:01:00 PM
Volume: 40,447

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.gkb.net
Market Cap 91.49 Cr.
Enterprise Value(EV) 93.15 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 8.45 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 21.49 Trailing Twelve Months Ending 2022-09
Industry PE 58.38 Trailing Twelve Months Ending 2022-09
Book Value / Share 131.64 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.38 Calculated using Price: 181.50
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.50 Cr. 5,040,580 Shares
FaceValue 10
Company Profile
The Company is engaged in the business of manufacturing and supply of semi - finished plastic lenses. It has manufacturing facilities at Tivim Industrial Estate, Mapusa - Goa.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.07%
1 Week
+25.25%
1 Month
+118.37%
3 Month
+52.17%
6 Month
+145.77%
1 Year
+114.77%
2 Year
+194.62%
5 Year
+49.41%
10 Year
+552.85%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 6.60 -3.30 9.32 5.65 -2.12 -2.52 -4.41 -1.23 3.09
Return on Capital Employed (%) 14.52 0.82 18.94 7.99 0.25 -0.34 -1.38 1.48 4.58
Return on Assets (%) 3.39 -1.78 5.48 3.34 -1.15 -1.36 -2.41 -0.69 1.73

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 40 40 45 47 45 55 59 63 63 65
Non Curr. Liab. 3 2 2 2 2 5 5 6 7 3
Curr. Liab. 30 33 23 37 36 37 41 38 40 43
Minority Int. 4 4 5
Equity & Liab. 73 75 69 86 83 97 106 111 114 116
Non Curr. Assets 29 29 18 19 19 33 33 37 38 23
Curr. Assets 43 46 51 66 64 64 73 74 76 93
Misc. Exp. not W/O
Total Assets 73 75 69 86 83 97 106 111 114 116

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 41 35 44 74 77 57 59 57 71 73
Other Income 1 1 2 1 0 2 1 2 1 1
Total Income 42 36 46 75 78 59 59 59 72 75
Total Expenditure -34 -34 -46 -72 -76 -56 -56 -55 -66 -66
PBIDT 8 1 0 3 2 3 3 4 6 9
Interest -3 -3 -2 -1 -1 -1 -1 -2 -1 -2
Depreciation -1 -2 -1 -1 -2 -4 -4 -3 -3 -2
Taxation -2 1 -4 0 0 0 0 0
Exceptional Items 0 1 11 3 -1
PAT 2 -1 4 3 -1 -1 -2 -1 2 5
Minority Interest 0 -1 -1
Share Associate 2 1 0 1 0
Other Related Items
Consolidated Net Profit 4 4 3 -1 -1 -2 -1 1 4
Adjusted EPS 10 0 10 6 -2 -2 -4 -2 3 8

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 3 6 7 -11 -3 -3 4 3 7 5
Cash Fr. Inv. -2 -2 -1 15 4 1 -10 -4 -17 -4
Cash Fr. Finan. -1 -5 -6 -3 -1 1 13 4 3 -2
Net Change 1 0 1 0 -1 0 7 4 -7 0
Cash & Cash Eqvt 2 2 3 3 2 2 9 13 6 6

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 49.52 59.44 59.24 59.58 59.69 59.72 59.73 59.16 59.09
Public 50.48 40.56 40.76 40.42 40.31 40.28 40.27 40.84 40.91
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 14 Jan 2023
Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015 - Imposition Of Anti-Dumping Duty On Import Of Semi Finished Ophthalmic Lenses.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform that the Ministry of Finance (Department of Revenue) Government of India vide its Notification No. 32/2022-Customs (ADD) dated December 27 2022 in the matter of semi-finished ophthalmic lenses falling under chapter heading 9001 of the First Schedule to the Customs Tariff Act 1975 (51 of 1975) imposed an anti-dumping duty. The anti-dumping duty imposed shall be effective for a period of five years from the date of publication of this notification in the Official Gazette and should be payable in Indian currency on semi finished lenses originating or exported from China PR.The Company which is a manufacturer of Semi finished ophthalmic lenses is of the opinion that the said Notification provides insufficient remedy to the issue of the industry and hence the Company has decided to go for an appeal.Kindly take the information on record.
Mon, 09 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Please find herewith Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2022.
Tue, 03 Jan 2023
Clarification On Price Movement
We refer to your email Ref: L/SURV/ONL/PV/KS/2022-2023/2921 dated January 02 2023 seeking clarification on significant movement in the share price of our Company in the recent past.In order to enable the investors to make well informed investment decisions the Company has been making to the Exchange adequate & accurate disclosures of all material events information etc. from time to time that have a bearing on operation/ performance of the Company which includes all price Sensitive Information as per Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulation 2015.There are media reports regarding imposition of Anti Dumping Duty on import of Semi finished Ophthalmic Lenses from China however we have not received the official gazetted copy & we cannot comment on the media reports.The Company has no pending announcements that may have a bearing on price/volume behavior script that is pending disclosure to the stock exchange at this point of time.

Technical Scans View Details >>

Wed, 25 Jan 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing 52 Week High Close Crossing 52 Week High
Closing Above Previous High Closing Above Previous High

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,518.84 1,040.75 +0.1%
Divi's Laboratories Ltd. 88,552.35 3,385.55 +1.5%
Cipla Ltd. 83,862.25 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 69,879.98 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 60,777.77 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,497.96 1,537.85 -1.3%
Abbott India Ltd. 45,101.64 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.79 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.71 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 32.68 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 22.47 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.39 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 65.87 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.15 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.33 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 3.83 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.36 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.15 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.62 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.62 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On GKB Ophthalmics Ltd.

What is GKB Ophthalmics share price?

Can I buy GKB Ophthalmics shares now?

What is the Market Cap of GKB Ophthalmics?

What are the key metrics to analyse GKB Ophthalmics?

What is the 52 Week High and Low of GKB Ophthalmics?

What is the trend of GKB Ophthalmics share price?